Stockscreener 앱 받기
70.19
0.21%
0.215
전일 마감가:
$69.97
열려 있는:
$69.01
하루 거래량:
3.02M
Relative Volume:
0.53
시가총액:
$27.35B
수익:
$4.52B
순이익/손실:
$720.70M
주가수익비율:
39.06
EPS:
1.7968
순현금흐름:
$1.06B
1주 성능:
-3.32%
1개월 성능:
+4.04%
6개월 성능:
-11.08%
1년 성능:
-20.39%
1일 변동 폭
$67.87
$70.14
1주일 범위
$67.87
$75.36
52주 변동 폭
$54.11
$93.25
덱스컴 Stock (DXCM) Company Profile
명칭
Dexcom Inc
전화
(858) 200-0200
주소
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Compare DXCM vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
70.13 | 27.29B | 4.52B | 720.70M | 1.06B | 1.7968 |
|
ABT
Abbott Laboratories
|
111.09 | 192.72B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
356.16 | 137.02B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
101.72 | 131.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.22 | 113.11B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.83 | 45.68B | 5.88B | 1.34B | 799.60M | 2.3489 |
덱스컴 Stock (DXCM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-12 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2025-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-25 | 개시 | Evercore ISI | In-line |
| 2025-10-21 | 재개 | Stifel | Buy |
| 2025-09-08 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-08-21 | 개시 | Argus | Buy |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-05-30 | 개시 | Goldman | Buy |
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-02-03 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | 개시 | Redburn Atlantic | Neutral |
| 2024-03-12 | 개시 | RBC Capital Mkts | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-04-17 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | 개시 | UBS | Buy |
| 2023-01-26 | 개시 | Wolfe Research | Outperform |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-15 | 개시 | Bernstein | Outperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-01-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2021-10-18 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-28 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2021-01-06 | 업그레이드 | UBS | Neutral → Buy |
| 2020-10-02 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | 재확인 | Piper Sandler | Overweight |
| 2020-05-14 | 개시 | Wells Fargo | Equal Weight |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-11-07 | 재확인 | Canaccord Genuity | Buy |
| 2019-11-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-10-23 | 개시 | Stifel | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-10-19 | 업그레이드 | Goldman | Sell → Neutral |
| 2018-09-12 | 업그레이드 | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | 재확인 | Canaccord Genuity | Buy |
| 2018-07-02 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-05-11 | 개시 | BofA/Merrill | Buy |
| 2018-05-03 | 재확인 | Canaccord Genuity | Buy |
| 2018-04-04 | 개시 | Goldman | Sell |
| 2018-04-04 | 개시 | Guggenheim | Neutral |
| 2018-03-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | 다운그레이드 | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | 재확인 | Wedbush | Outperform |
모두보기
덱스컴 주식(DXCM)의 최신 뉴스
DexCom upgraded at Morgan Stanley on sorting out operational issues - MSN
DexCom’s AI Powered Stelo Pushes Deeper Into Consumer Metabolic Health - Yahoo Finance
August 21st Options Now Available For DexCom (DXCM) - Nasdaq
DexCom Expands Stelo AI Tools As It Seeks Stickier CGM Users - simplywall.st
A Look Into DexCom Inc's Price Over Earnings - Benzinga
DexCom (DXCM) Reports Next Week: Wall Street Expects Earnings Growth - Finviz
DXCM Upgrades Stelo With AI-Powered Smart Meal Logging Features - TradingView
Growth Value: Should I average down on DexCom Inc stockWeekly Risk Report & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
DexCom’s CEO Believes Diabetics On GLP-1s Should Also Wear CGMs - MedCity News
Risks Report: Is DexCom Inc a strong growth stockJuly 2025 Retail & Daily Growth Stock Tips - baoquankhu1.vn
Dexcom adds enhanced smart meal logging feature to Stelo CGM - MassDevice
Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management - Eagle-Tribune
Continuous Glucose Monitoring Devices Market to Reach US$10.72 - openPR.com
Does DexCom (NASDAQ:DXCM) Have A Healthy Balance Sheet? - 富途牛牛
New Dexcom CEO Takes on ‘Thrilling’ Task Leading CGM Giant - San Diego Business Journal
Continuous Glucose Monitoring Market to Grow at a Robust CAGR - openPR.com
Peterson Wealth Services Grows Stock Position in DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. (DXCM) Stock Analysis: Exploring a 16.64% Upside Potential in the Growing Medical Devices Sector - DirectorsTalk Interviews
What DexCom (DXCM)'s Strong Q4 Beat and Margin Guidance Means For Shareholders - Sahm
DexCom Faces Split Analyst Views As Competition Pressures Core CGM Markets - Sahm
DexCom’s Q4 Beat And 2026 Targets Tested By Rising CGM Competition - Yahoo Finance
What DexCom (DXCM)'s Strong Q4 Beat and 2026 Margin Guidance Means For Shareholders - Yahoo Finance
DexCom, Inc. $DXCM Shares Purchased by Mirae Asset Global Investments Co. Ltd. - MarketBeat
Q4 Preliminary Figures and 2026 Guidance Make DexCom (DXCM) Look Attractive - Insider Monkey
Investigation into DexCom's Corporate Governance Breaches - Intellectia AI
HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PR Newswire
Price Over Earnings Overview: DexCom - Sahm
DexCom, Inc. $DXCM Holdings Cut by J. Safra Sarasin Holding AG - MarketBeat
Here's Why DexCom (DXCM) is a Strong Momentum Stock - Yahoo Finance
Federated Hermes Inc. Trims Position in DexCom, Inc. $DXCM - MarketBeat
Is DexCom (DXCM) Pricing Reflect Longer Term Returns And Glucose Monitoring Growth Story - Yahoo Finance
Hussman Strategic Advisors Inc. Takes $2.83 Million Position in DexCom, Inc. $DXCM - MarketBeat
Barclays Downgrades Dexcom (DXCM) to Underweight Citing Intensifying Competition in Core Segments - Finviz
Y Intercept Hong Kong Ltd Purchases New Position in DexCom, Inc. $DXCM - MarketBeat
Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time. - Chartmill
INVESTOR NOTICE: Kaskela Law Firm Announces Stockholder Investigation of DexCom, Inc. (NASDAQ - marketscreener.com
Intact Investment Management Inc. Has $2.28 Million Stock Position in DexCom, Inc. $DXCM - MarketBeat
CIBC Asset Management Inc Has $10.51 Million Holdings in DexCom, Inc. $DXCM - MarketBeat
12 Best US Stocks to Buy and Hold in 2026 - Insider Monkey
Mitsubishi UFJ Trust & Banking Corp Sells 102,717 Shares of DexCom, Inc. $DXCM - MarketBeat
Strs Ohio Sells 14,796 Shares of DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. $DXCM Shares Purchased by Sector Gamma AS - MarketBeat
Rakuten Investment Management Inc. Buys New Position in DexCom, Inc. $DXCM - MarketBeat
Here's why you should hold DexCom stock in your portfolio for now - MSN
How Investors Are Reacting To DexCom (DXCM) Revenue Guidance After G7 Recall and CGM Expansion Plans - simplywall.st
Jennison Associates LLC Has $678.98 Million Stock Holdings in DexCom, Inc. $DXCM - MarketBeat
Teacher Retirement System of Texas Acquires 92,643 Shares of DexCom, Inc. $DXCM - MarketBeat
Baillie Gifford & Co. Sells 823,027 Shares of DexCom, Inc. $DXCM - MarketBeat
New DexCom CEO Remains Focused on Addressing Recent Quality Issues - morningstar.com
DexCom Inc (DXCM) Trading 4.47% Higher on Jan 22 - GuruFocus
Campbell & CO Investment Adviser LLC Has $629,000 Holdings in DexCom, Inc. $DXCM - MarketBeat
덱스컴 (DXCM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.49%
2.59%
자본화:
|
볼륨(24시간):